Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In-vivo studies on Haemaccel-fibronectin interaction in man.

P Damas, A Adam, J Buret

    European Journal of Clinical Investigation
    |April 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Esophageal cancer: self-expanding metallic stents.

    Abdominal imaging·2005
    Same author

    Abundance and location of DARPP-32 in striato-tegmental circuits of domestic chicks.

    Journal of chemical neuroanatomy·2004
    Same author

    The use of SMARTeR stents in patients with biliary obstruction.

    Clinical radiology·2004
    Same author

    Trans-oral embolization of a post-operative duodenocutaneous fistula.

    Clinical radiology·2003
    Same author

    Registration of freehand 3D ultrasound and magnetic resonance liver images.

    Medical image analysis·2003
    Same author

    Bronchogastric fistula successfully treated with the insertion of a covered bronchial stent.

    European radiology·2003
    Same journal

    Pacemaker Status and 5-Year Mortality After TAVI: A Sex-Specific Analysis.

    European journal of clinical investigation·2026
    Same journal

    Causal Effects of Time-Varying Treatments: The G-Formula.

    European journal of clinical investigation·2026
    Same journal

    Improving Scientific Research: Renegotiated Principles of Science, Proposals, Failures, and Successes.

    European journal of clinical investigation·2026
    Same journal

    Beta-Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta-Analysis With Trial Sequential Analysis.

    European journal of clinical investigation·2026
    Same journal

    Prognostic Role of Serum Albumin Levels in Elderly Patients With Non-Valvular Atrial Fibrillation.

    European journal of clinical investigation·2026
    Same journal

    Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery Disease.

    European journal of clinical investigation·2026
    See all related articles

    Haemaccel infusion inhibits plasma fibronectin

    Area of Science:

    • Biochemistry
    • Immunology

    Background:

    • Plasma fibronectin (FN) plays a crucial role in the immune system.
    • Fibronectin's gelatin-binding capacity is vital for its function.
    • Haemaccel, a plasma expander, is investigated for its interaction with fibronectin.

    Purpose of the Study:

    • To investigate the effect of Haemaccel on the gelatin-binding capacity of plasma fibronectin.
    • To determine the mechanism of interaction between Haemaccel and fibronectin in vivo and in vitro.

    Main Methods:

    • Enzyme-linked immunoassay (ELISA) for fibronectin-gelatin binding capacity.
    • Laser nephelometry for immunoreactive fibronectin levels.
    • Gel filtration and affinity chromatography for complex formation.
    • In vivo infusion studies in human volunteers.

    Related Experiment Videos

    Main Results:

    • Haemaccel, but not Geloplasma, inhibited fibronectin-gelatin binding in vitro.
    • In vivo Haemaccel infusion dose-dependently reduced fibronectin-gelatin binding capacity.
    • Fibronectin-Haemaccel complexes were formed, with delayed clearance.
    • Immunoreactive fibronectin levels showed a transient decline after Haemaccel infusion.

    Conclusions:

    • Haemaccel directly interferes with fibronectin's gelatin-binding ability.
    • Plasma fibronectin is cleared via Haemaccel-mediated complex formation.
    • Fibronectin does not appear to act as an opsonin in the context of Haemaccel administration.